Vonoprazan is the first member of a new class of drugs known as Potassium-Competitive Acid Blockers (P-CABs) discovered and synthesised by the Takeda Pharmaceutical Company for the treatment of Reflux Esophagitis as well as other acid peptic diseases such as GERD, gastric and duodenal ulcers, and H. pylori elimination treatment. In contrast to proton pump inhibitors, Vonoprazan inhibits acid using a new mechanism, which is reversible and potassium-competitive and therefore acts very quickly and consistently throughout the day, independent of the acidic environment.
Since 2024, a number of large Indian pharmaceutical companies have entered into non-exclusive license agreements with Takeda to market Vonoprazan in India under their own brand names. Since Vonoprazan is a relatively new drug to be launched in India, the brands listed below are supported by highly reliable sources – most of the sources being official company press releases or stock exchange filings.
Top Vonoprazan Tablet Brands in India
Vonzai
This brand of Vonoprazan is manufactured and marketed by Alkem Laboratories Ltd., one of India's leading pharmaceutical companies. It is licensed from Takeda Pharmaceutical Company through a non-exclusive patent license agreement. The company enjoys a large scale and an established distribution network across the country for the product, and this makes Vonzai easily available after its launch.
Marketer / Manufacturer: Alkem Laboratories Ltd.
Composition / Strength: Vonoprazan Fumarate 10 mg / 20 mg, tablet
Pack Size: 10 tablets per strip
- Licensed directly from Takeda via official patent license agreement
- Backed by Alkem, one of India's leading pharmaceutical companies
- 10 mg & 20 mg strengths
Vono
It is manufactured and marketed by Dr Reddy's Laboratories Ltd. The company has been manufacturing Vonoprazan under a direct licensing agreement from Takeda Pharmaceutical Company. Dr Reddy's has over three decades of experience in the Indian GI segment, and it has been successfully selling Omez and Razo to gastroenterologists.
Marketer / Manufacturer: Dr Reddy's Laboratories Ltd.
Composition / Strength: Vonoprazan 10 mg / 20 mg, tablet
Pack Size: 10 tablets per strip
- Licensed directly from Takeda; announced officially through a company press release
- Backed by Dr Reddy's three-decade experience in the Indian GI therapy segment
- 10 mg & 20 mg strengths
Vonefi
Vonefi is marketed by Abbott India Ltd. under a non-exclusive patent license agreement with Takeda, officially announced to position Abbott as a leader in the gut-health space in India. Abbott's global manufacturing standards and established prescriber trust give Vonefi strong positioning in both hospital and retail pharmacy channels.
Marketer / Manufacturer: Abbott India Ltd.
Composition / Strength: Vonoprazan, tablet
Pack Size: 10 tablets per strip
- Licensed directly from Takeda; confirmed via multiple official company announcements
- Backed by Abbott India's global manufacturing and quality standards
- Positioned as part of Abbott's broader gut-health portfolio
Zanvolis-20
Zanvolis-20 is a Vonoprazan 20 mg tablet brought out by Eridanus Healthcare, described in their official product description as a new-launch product. Zanvolis-20 is said to belong to the relatively new Potassium-Competitive Acid Blocker (P-CAB) group and is targeted at gastrointestinal issues caused by acids such as GERD, peptic ulcer, erosive esophagitis and H. pylori eradication therapy. The packaging of the product is 10×10 ALU-ALU, and the franchise is open to PCD Pharma Franchise opportunities in India.
Marketer/Manufacturer: Eridanus Healthcare
Composition/Strength: Vonoprazan 20 mg, tablet
Pack size: 10×10 ALU-ALU box
- New-launch Vonoprazan 20 mg tablet from Eridanus Healthcare
- Belongs to the Potassium-Competitive Acid Blocker (P-CAB) group
- Targeted at GERD and H. pylori eradication therapy
Vault
Vault is marketed by Zydus Lifesciences under a direct licensing agreement with Takeda. Zydus has a long legacy in India's GERD and acid-peptic disorder segment, having introduced Pantoprazole to the Indian market in 1999 and built established brands like Pantodac and Ocid, giving Vault strong brand-family credibility among prescribers.
Marketer / Manufacturer: Zydus Lifesciences Ltd.
Composition / Strength: Vonoprazan, tablet
Pack Size: 10 tablets per strip
- Licensed directly from Takeda; confirmed via official company announcement
- Backed by Zydus's established GERD portfolio (Pantodac, Happi, Ocid)
- Zydus was the first company to introduce Pantoprazole in India in 1999
Vonalong
Vonalong is sold by Mankind Pharma, which is one of the biggest pharmaceutical companies in India with a very strong retail/pharmacy reach in tier-2 and tier-3 cities. The strong distribution channels make Vonalong available to the stockists who wish to launch Vonoprazan as a treatment in tier-2 and tier-3 cities.
Marketer / Manufacturer: Mankind Pharma Ltd.
Composition / Strength: Vonoprazan 20 mg, tablet
Pack Size: 10 tablets per strip
- Strong distribution through Mankind Pharma in tier-2 and tier-3 retail
- One of the earliest companies to have secured the Takeda license agreement
- Positioned 20 mg for GERD, ulcers and acid-related diseases
Vonatime
Vonatime is sold by Eris Lifesciences, which is an Indian pharmaceutical company with a growing focus on therapeutics for chronic and lifestyle diseases. The speciality focus of Eris makes Vonatime have a distinctive position among the newer players of this molecule.
Marketer / Manufacturer: Eris Lifesciences Ltd.
Composition / Strength: Vonoprazan 20 mg, tablet
Pack Size: 10 tablets per strip
- Positioned as a speciality portfolio by Eris Lifesciences, focused on chronic and lifestyle diseases
- Positioned 20 mg for acid-related diseases
- Newer entrant providing an alternative to the bigger licensed brands
Kabvie
Kabvie is formulated by Torrent Pharmaceuticals, a major Indian pharmaceutical company known for its GMP-certified manufacturing and quality assurance standards. Torrent's established presence in the gastrointestinal therapeutic segment supports Kabvie's positioning for GERD, peptic ulcers, and H. pylori-related conditions.
Marketer / Manufacturer: Torrent Pharmaceuticals Ltd.
Composition / Strength: Vonoprazan 20 mg, tablet
Pack Size: 10 tablets per strip
- Backed by Torrent Pharmaceuticals' GMP-certified manufacturing
- Positioned for GERD, peptic ulcers, and H. pylori infections
- Note: sourced from a single corroborating listing — confirm current marketer details before stocking
Lupivon
Lupivon is formulated by Lupin, a major Indian pharmaceutical company, with manufacturing stated to meet WHO-GMP, USFDA, and other global quality standards. Lupin's scale and international regulatory track record give Lupivon strong quality credentials among the newer Vonoprazan entrants.
Marketer / Manufacturer: Lupin Ltd.
Composition / Strength: Vonoprazan 20 mg, tablet
Pack Size: 10 tablets per strip
- Backed by Lupin, meeting WHO-GMP and USFDA quality standards
- 20 mg strength positioned for GERD and acid-related disorders
Final Thoughts
This new molecule in India has a brand map that is well-defined as the bigger companies like Alkem, Dr. Reddy's, Abbott, Zydus, and Mankind all released their licenses from Takeda in press statements and stock exchange documents, thus providing distributors with much certainty about which company makes each brand. Since this molecule is relatively new, we would suggest you to verify your stock levels and pricing with each individual company as regional distribution networks for newly launched molecules are often not yet fully developed.
